MedPath

Effect of Crocin and Metformin in patients with type 2 diabetes

Phase 3
Completed
Conditions
Type 2 Diabetes.
Type 2 diabetes mellitus
Registration Number
IRCT20170611034458N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with type 2 diabetes treated by metformin
Aged 35-75 years old

Exclusion Criteria

Hypertension
Patients with other endocrine, liver, kidney, inflammatory and lung disorders
Taking metformin in combination with other anti-diabetic drugs
Take any other antioxidant supplement
Alcohol-drug abuse
Pregnant women
Patients with type 1 diabetes

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.